P

Inventor

RUI LINGYUN

US36 patents
⚠️ This page may combine multiple inventors who share the name “RUI LINGYUN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

IMMUNOGEN INC

23 patents
US9670279B2Jun 6, 2017

Folate receptor 1 antibodies and immunoconjugates and uses thereof

IMMUNOGEN INC26 citations98
US9133275B2Sep 15, 2015

Folate receptor 1 antibodies and immunoconjugates and uses thereof

IMMUNOGEN INC45 citations98
US10752683B2Aug 25, 2020

Folate receptor 1 antibodies and immunoconjugates and uses thereof

IMMUNOGEN INC13 citations94
US10301385B2May 28, 2019

Folate receptor 1 antibodies and immunoconjugates and uses thereof

IMMUNOGEN INC8 citations92
US10077313B2Sep 18, 2018

Anti-CD123 antibodies and conjugates and derivatives thereof

IMMUNOGEN INC12 citations92
US10017578B2Jul 10, 2018

Methods of treating cancer in a patient by administering anti-folate-receptor-1 (FOLR1) antibodies

IMMUNOGEN INC12 citations92
US9670278B2Jun 6, 2017

Folate receptor 1 antibodies and immunoconjugates and uses thereof

IMMUNOGEN INC18 citations92
US9670280B2Jun 6, 2017

Folate receptor 1 antibodies and immunoconjugates and uses thereof

IMMUNOGEN INC19 citations92
US9657100B2May 23, 2017

Folate receptor 1 antibodies and immunoconjugates and uses thereof

IMMUNOGEN INC16 citations92
US9637547B2May 2, 2017

Monoclonal antibodies for detection of folate receptor 1

IMMUNOGEN INC15 citations92
US9598490B2Mar 21, 2017

Folate receptor 1 antibodies and immunoconjugates and uses thereof

IMMUNOGEN INC18 citations92
US9346887B2May 24, 2016

CD37-binding molecules and immunoconjugates thereof

IMMUNOGEN INC12 citations92
US10919969B2Feb 16, 2021

Anti-CD123 antibodies and conjugates and derivatives thereof

IMMUNOGEN INC4 citations83
US10544230B2Jan 28, 2020

Methods of using antibodies to detect folate receptor 1 (FOLR1)

IMMUNOGEN INC4 citations83
US10442865B2Oct 15, 2019

Methods of use of anti-CD123 antibodies and antigen-binding fragments thereof

IMMUNOGEN INC4 citations83
US11198736B2Dec 14, 2021

Method for identifying an ovarian cancer in a subject likely to respond to anti-folate receptor 1 (FOLR1) antibody

IMMUNOGEN INC5 citations81
US11932701B2Mar 19, 2024

Method for increasing the efficacy of cancer therapy by administering an anti-FOLR1 immunoconjugate

IMMUNOGEN INC1 citations72
US11332535B2May 17, 2022

Anti-CD123 antibodies and conjugates and derivatives thereof

IMMUNOGEN INC2 citations72
US10875925B2Dec 29, 2020

Anti-CD123 antibodies and conjugates and derivatives thereof

IMMUNOGEN INC3 citations72
US11897961B2Feb 13, 2024

Anti-CD123 antibodies and conjugates and derivatives thereof

IMMUNOGEN INC0 citations62
US9125896B2Sep 8, 2015

EGFR-binding molecules and immunoconjugates thereof

IMMUNOGEN INC3 citations62
US11732038B2Aug 22, 2023

Conjugates comprising cell-binding agents and cytotoxic agents

IMMUNOGEN INC0 citations60
US10988531B2Apr 27, 2021

Conjugates comprising cell-binding agents and cytotoxic agents

IMMUNOGEN INC1 citations60

DEBIOPHARM INT SA

4 patents

CUGENE INC

4 patents

DECKERT JUTTA

2 patents

SETIADY JULIANTO

2 patents

AB OLGA

1 patent